Creative Planning - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 246 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 0.69 and the average weighting 0.1%.

Quarter-by-quarter ownership
Creative Planning ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2024$227,582
+6348.9%
6,672
+5112.5%
0.00%
Q3 2023$3,529
-99.4%
128
-99.3%
0.00%
-100.0%
Q2 2019$570,000
+21.3%
17,228
+28.3%
0.00%0.0%
Q1 2019$470,000
+60.4%
13,426
+52.2%
0.00%
+100.0%
Q4 2018$293,000
-71.9%
8,824
-57.3%
0.00%
-75.0%
Q3 2018$1,042,000
-16.0%
20,688
-0.1%
0.00%
-20.0%
Q2 2018$1,240,000
+66.0%
20,719
+27.1%
0.01%
+66.7%
Q1 2018$747,000
-15.1%
16,304
-26.2%
0.00%
-25.0%
Q4 2017$880,000
-12.1%
22,078
-11.8%
0.00%
-20.0%
Q3 2017$1,001,000
+27.2%
25,034
+37.1%
0.01%
+25.0%
Q2 2017$787,000
+130.8%
18,254
+67.4%
0.00%
+100.0%
Q1 2017$341,000
+337.2%
10,905
+251.8%
0.00%
Q4 2016$78,000
-4.9%
3,100
-6.3%
0.00%
-100.0%
Q3 2016$82,000
+30.2%
3,310
+6.8%
0.00%
Q2 2016$63,000
+34.0%
3,1000.0%0.00%
Q1 2016$47,000
+11.9%
3,100
-1.6%
0.00%
Q4 2015$42,000
-4.5%
3,1510.0%0.00%
Q3 2015$44,000
+22.2%
3,151
+5.0%
0.00%
Q1 2015$36,000
+44.0%
3,0000.0%0.00%
Q4 2014$25,000
-3.8%
3,0000.0%0.00%
Q3 2014$26,000
-21.2%
3,0000.0%0.00%
Q2 2014$33,000
+22.2%
3,0000.0%0.00%
Q1 2014$27,000
+17.4%
3,0000.0%0.00%
Q4 2013$23,000
+4.5%
3,0000.0%0.00%
Q3 2013$22,0003,0000.00%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q3 2019
NameSharesValueWeighting ↓
NEA Management Company, LLC 7,641,250$107,207,0007.06%
HealthInvest Partners AB 782,746$10,982,0006.50%
KOPP INVESTMENT ADVISORS LLC 729,960$10,241,0005.51%
Murphy Michael R 1,028,304$14,427,0004.96%
Opaleye Management Inc. 460,000$6,454,0003.18%
ASHFORD CAPITAL MANAGEMENT INC 511,244$7,173,0001.68%
Bruce & Co., Inc. 394,581$5,535,0001.42%
AlphaOne Investment Services, LLC 235,065$3,297,0001.40%
Ranger Investment Management 1,560,453$21,893,0001.23%
NORTHPOINTE CAPITAL LLC 584,753$8,204,0001.07%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders